Insider · CIK 0001591070

SARAN ATUL

Reports to the SEC for 3 companies · MONROVIA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001591070

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-28	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−971 sh	$12.38	−$12K	86,645
2023-02-24	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−845 sh	$13.71	−$11.6K	87,616
2023-02-23	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−365 sh	$14.30	−$5,219.5	88,461
2023-02-08	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+95 sh	—	—	90,877
2023-02-08	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−2,051 sh	$13.25	−$27.2K	88,826
2022-03-01	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+31.4K sh	—	—	74,630
2022-03-01	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+16.9K sh	—	—	91,546
2022-03-01	EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+38.7K sh	$41.38	+$1.6M	38,664
2022-02-28	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−764 sh	$39.64	−$30.3K	90,782
2022-02-24	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−857 sh	$42.47	−$36.4K	43,213
2022-02-23	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−442 sh	$42.23	−$18.7K	44,070
2022-02-22	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+1,836 sh	—	—	46,596
2022-02-22	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−2,084 sh	$42.23	−$88K	44,512
2021-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−764 sh	$97.15	−$74.2K	45,559
2021-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−799 sh	$97.15	−$77.6K	44,760
2021-02-24	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+3,744 sh	—	—	43,466
2021-02-24	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+3,744 sh	—	—	47,210
2021-02-24	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−887 sh	$93.49	−$82.9K	46,323
2021-02-24	EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+15K sh	$93.49	+$1.4M	14,973
2021-02-09	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+2,656 sh	—	—	42,152
2021-02-09	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−2,430 sh	$123.45	−$300K	39,722
2020-08-07	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−1,303 sh	$126.96	−$165K	39,496
2020-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−508 sh	$59.91	−$30.4K	41,381
2020-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−582 sh	$59.91	−$34.9K	40,799
2020-02-25	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,697 sh	—	—	36,192
2020-02-25	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,697 sh	—	—	41,889
2020-02-25	EBSEmergent BioSolutions Inc. · Employee Stock Options (Right to Buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+22.8K sh	$61.44	+$1.4M	43,105
2019-08-07	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−1,287 sh	$44.47	−$57.2K	30,495
2019-02-26	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−534 sh	$61.01	−$32.6K	21,620
2019-02-26	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,081 sh	—	—	26,701
2019-02-26	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,081 sh	—	—	31,782
2019-02-26	EBSEmergent BioSolutions Inc. · Employee Stock Option (Right to Buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+20.3K sh	$61.01	+$1.24M	20,321
2018-08-07	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Chief Strat & Dev Officer	FTax Payment	−1,286 sh	$54.65	−$70.3K	22,154
2018-02-27	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,313 sh	—	—	18,127
2018-02-27	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+5,313 sh	—	—	23,440
2018-02-27	EBSEmergent BioSolutions Inc. · Employee stock option (right to buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+21.3K sh	$49.64	+$1.05M	21,253
2017-08-08	EBSEmergent BioSolutions Inc.A Award	EVP, Chief Strat & Dev Officer	AAward	+12.8K sh	—	—	12,814
2017-08-08	EBSEmergent BioSolutions Inc. · Employee stock option (right to buy)A Award	EVP, Chief Strat & Dev Officer	AAward	+20.1K sh	—	—	20,083
2017-04-28	MGNXMACROGENICS INCF Tax Payment	SVP & General Counsel	FTax Payment	−1,862 sh	$21.61	−$40.2K	16,986
2017-02-15	MGNXMACROGENICS INC · Common StockA Award	SVP & General Counsel	AAward	+55K sh	$20.53	+$1.13M	55,000
2016-04-28	MGNXMACROGENICS INCF Tax Payment	SVP & General Counsel	FTax Payment	−1,862 sh	$20.84	−$38.8K	18,848
2016-04-28	MGNXMACROGENICS INCF Tax Payment	SVP & General Counsel	FTax Payment	−1,730 sh	$20.84	−$36.1K	18,980
2015-12-18	MGNXMACROGENICS INC · Employee Stock Option (right to buy)A Award	SVP & General Counsel	AAward	+45K sh	—	—	45,000
2015-04-28	MGNXMACROGENICS INCF Tax Payment	SVP & General Counsel	FTax Payment	−925 sh	$32.02	−$29.6K	20,710
2014-12-12	MGNXMACROGENICS INC · Employee Stock Option (right to buy)A Award	SVP & General Counsel	AAward	+30K sh	—	—	30,000
2014-10-28	MGNXMACROGENICS INCF Tax Payment	SVP & General Counsel	FTax Payment	−865 sh	$21.79	−$18.8K	21,635
2013-12-06	XNCRXencor IncC Conversion	Director	CConversion	+1.32M sh	—	—	1,319,522
2013-12-06	XNCRXencor Inc · Series A-1 Preferred StockC Conversion	Director	CConversion	−4.09M sh	—	—	0

Recent filings

Accepted (ET)
Mar 24
SARAN ATUL0001367644-23-000058
SEC(opens sec.gov)
Feb 274
SARAN ATUL0001367644-23-000037
SEC(opens sec.gov)
Feb 104
SARAN ATUL0001367644-23-000015
SEC(opens sec.gov)
Mar 24
SARAN ATUL0001367644-22-000041
SEC(opens sec.gov)
Feb 254
SARAN ATUL0001367644-22-000033
SEC(opens sec.gov)
Feb 244
SARAN ATUL0001367644-22-000018
SEC(opens sec.gov)
Feb 264
SARAN ATUL0001367644-21-000043
SEC(opens sec.gov)
Feb 114
SARAN ATUL0001367644-21-000017
SEC(opens sec.gov)

Companies

Address

C/O XENCOR, INC. 111 WEST LEMON AVENUE

MONROVIA, CA, 91016